Ocular Therapeutix Investor Relations Material
Latest events
Q4 2024
Ocular Therapeutix
Q1 2025
5 May, 2025
Corporate Presentation
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ocular Therapeutix Inc
Access all reports
Ocular Therapeutix Inc is a biopharmaceutical company focused on the development and commercialization of therapies for diseases and conditions of the eye. The company specializes in proprietary hydrogel-based drug delivery platforms designed for ophthalmology treatments. Ocular Therapeutix serves the healthcare sector by addressing needs in areas such as post-surgical inflammation, dry eye disease, and retinal diseases. The company is headquartered in Bedford, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Ocular Therapeutix Inc
Corporate Presentation
Ocular Therapeutix Inc
Corporate Presentation
Ocular Therapeutix Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
OCUL
Country
🇺🇸 United States